Your browser doesn't support javascript.
loading
Heterogeneity in glucose response curves during an oral glucose tolerance test and associated cardiometabolic risk.
Hulman, Adam; Simmons, Rebecca K; Vistisen, Dorte; Tabák, Adam G; Dekker, Jacqueline M; Alssema, Marjan; Rutters, Femke; Koopman, Anitra D M; Solomon, Thomas P J; Kirwan, John P; Hansen, Torben; Jonsson, Anna; Gjesing, Anette Prior; Eiberg, Hans; Astrup, Arne; Pedersen, Oluf; Sørensen, Thorkild I A; Witte, Daniel R; Færch, Kristine.
Afiliación
  • Hulman A; Department of Public Health, Section of Epidemiology, Aarhus University, Aarhus, Denmark. adam.hulman@ph.au.dk.
  • Simmons RK; Danish Diabetes Academy, Odense, Denmark. adam.hulman@ph.au.dk.
  • Vistisen D; Department of Medical Physics and Informatics, University of Szeged, Szeged, Hungary. adam.hulman@ph.au.dk.
  • Tabák AG; Danish Diabetes Academy, Odense, Denmark.
  • Dekker JM; Department of Public Health, Section of General Practice, Aarhus University, Aarhus, Denmark.
  • Alssema M; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.
  • Rutters F; Steno Diabetes Center, Gentofte, Denmark.
  • Koopman AD; 1st Department of Medicine, Semmelweis University Faculty of Medicine, Budapest, Hungary.
  • Solomon TP; Department of Epidemiology and Public Health, University College London, London, UK.
  • Kirwan JP; Department of Biostatistics and Epidemiology, VU Medical Center, Amsterdam, Netherlands.
  • Hansen T; EMGO+ Institute for Health and Care Research, VU Medical Center, Amsterdam, Netherlands.
  • Jonsson A; Department of Biostatistics and Epidemiology, VU Medical Center, Amsterdam, Netherlands.
  • Gjesing AP; Unilever Research and Development, Vlaardingen, Netherlands.
  • Eiberg H; Department of Biostatistics and Epidemiology, VU Medical Center, Amsterdam, Netherlands.
  • Astrup A; EMGO+ Institute for Health and Care Research, VU Medical Center, Amsterdam, Netherlands.
  • Pedersen O; Department of Biostatistics and Epidemiology, VU Medical Center, Amsterdam, Netherlands.
  • Sørensen TI; EMGO+ Institute for Health and Care Research, VU Medical Center, Amsterdam, Netherlands.
  • Witte DR; School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Edgbaston, UK.
  • Færch K; Institute for Metabolism and Systems Research, University of Birmingham, Edgbaston, UK.
Endocrine ; 55(2): 427-434, 2017 Feb.
Article en En | MEDLINE | ID: mdl-27699707
We aimed to examine heterogeneity in glucose response curves during an oral glucose tolerance test with multiple measurements and to compare cardiometabolic risk profiles between identified glucose response curve groups. We analyzed data from 1,267 individuals without diabetes from five studies in Denmark, the Netherlands and the USA. Each study included between 5 and 11 measurements at different time points during a 2-h oral glucose tolerance test, resulting in 9,602 plasma glucose measurements. Latent class trajectories with a cubic specification for time were fitted to identify different patterns of plasma glucose change during the oral glucose tolerance test. Cardiometabolic risk factor profiles were compared between the identified groups. Using latent class trajectory analysis, five glucose response curves were identified. Despite similar fasting and 2-h values, glucose peaks and peak times varied greatly between groups, ranging from 7-12 mmol/L, and 35-70 min. The group with the lowest and earliest plasma glucose peak had the lowest estimated cardiovascular risk, while the group with the most delayed plasma glucose peak and the highest 2-h value had the highest estimated risk. One group, with normal fasting and 2-h values, exhibited an unusual profile, with the highest glucose peak and the highest proportion of smokers and men. The heterogeneity in glucose response curves and the distinct cardiometabolic risk profiles may reflect different underlying physiologies. Our results warrant more detailed studies to identify the source of the heterogeneity across the different phenotypes and whether these differences play a role in the development of type 2 diabetes and cardiovascular disease.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glucemia / Intolerancia a la Glucosa / Diabetes Mellitus Tipo 2 Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte / Europa Idioma: En Revista: Endocrine Asunto de la revista: ENDOCRINOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glucemia / Intolerancia a la Glucosa / Diabetes Mellitus Tipo 2 Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte / Europa Idioma: En Revista: Endocrine Asunto de la revista: ENDOCRINOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Dinamarca
...